MarketPulse
A

$ANIX

2 articles found
2 positive
0 negative
0 neutral
BenzingaBenzinga··Prnewswire

Anixa Biosciences Secures Mexican Patent for Breast Cancer Vaccine Through 2040

Anixa Biosciences secures Mexican patent for breast cancer vaccine extending protection through 2040, supporting Phase 2 trial advancement.
ANIXPhase 2 clinical trialintellectual property
BenzingaBenzinga··Prnewswire

Anixa Secures Korean Patent for Breast Cancer Vaccine, Bolstering IP Portfolio

Anixa Biosciences secures patent protection in South Korea for breast cancer vaccine technology, advancing its IP portfolio as Phase 1 trial shows 74% immune response rate.
ANIXintellectual propertyclinical trial